Disposable CGM Approved; Mounjaro Tied to Reduced Mortality; Benefits of Lignins

Medtronic announced FDA approval of its first disposable, all-in-one continuous glucose monitor (CGM) Simplera, which is half the size of the maker’s previous devices.

Over a median follow-up of 10.5 months, the dual GIP/GLP-1 receptor agonist tirzepatide (Mounjaro) for adults with type 2 diabetes was associated with a 42% reduced risk of death, a 20% reduced risk of major adverse cardiovascular events, and a 46% reduced risk of major adverse kidney events versus a GLP-1 receptor agonist. (JAMA Network Open)

Hypoparathyroidism was a frequent complication following total thyroidectomy and was linked with an increased risk for developing chronic kidney disease in a Danish study. (Journal of Clinical Endocrinology & Metabolism)

Most U.S. patients on semaglutide (Wegovy) for weight loss take it for just 6 months. (Reuters)

Meanwhile, semaglutide-maker Novo Nordisk withdrew an application with the FDA that aimed to expand indications for the weight-loss drug to include heart failure and kidney disease. The drugmaker said it plans to resubmit in early 2025 with more data, including from its FLOW kidney outcomes trial.

Initial findings suggested type 2 diabetes remission with a total diet replacement program was possible outside of research settings. (Lancet Diabetes & Endocrinology)

Eating more lignin-rich foods — polyphenolic chemicals found in plant-based foods like seeds, whole grains, fruits, and vegetables — was associated with a lower type 2 diabetes risk in an observational study. (JAMA Network Open)

Here are the 26 U.S. counties with the highest rates of adult obesity. (U.S. News & World Report)

The 1-mg dexamethasone suppression test had a specificity of 99% and sensitivity of 100% in screening for Cushing’s syndrome in people with obesity, but nearly all cases it picked up were among patients with a metabolically unhealthy obesity phenotype. (International Journal of Obesity)

Compared with unexposed controls, fetal exposure to famine shortly after conception was linked to a more-than twofold greater risk of type 2 diabetes in adulthood. (Science)

“Star Wars” actress Daisy Ridley recently opened up about her Graves’ disease. (Women’s Health)

Among younger veterans with type 2 diabetes and post-traumatic stress disorder (PTSD) followed for up to 9 years, no longer meeting criteria for PTSD was associated with lower risks of starting insulin and all-cause mortality. (JAMA Network Open)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.

Please enable JavaScript to view the

comments powered by Disqus.